GLP1R gene variant is associated with glycaemic response to treatment with DPP-4 inhibitors

被引：0
|
作者：
Javorsky, M. [1 ,2 ]
Gotthardova, I. [1 ]
Klimcakova, L. [3 ]
Kvapil, M. [4 ,5 ]
Schroner, Z. [1 ]
Doubravova, P. [4 ]
Zidzik, J. [3 ]
Gal'a, I. [1 ]
Dravecka, I. [6 ]
Tkac, I. [1 ]
机构：
[1] Safarik Univ, Sch Med, Dept Med 4, Kosice, Slovakia
[2] Pasteur Teaching Hosp, Kosice, Slovakia
[3] Safarik Univ, Sch Med, Inst Med Biol & Genet, Kosice, Slovakia
[4] Fac Med 2, Prague, Czech Republic
[5] Fac Hosp Motol, Prague, Czech Republic
[6] Safarik Univ, Sch Med, Dept Med 1, Kosice, Slovakia
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
783
引用
收藏
页码：S373 / S374
页数：2
相关论文
共 50 条
  • [21] The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system
    Schernthaner, Guntram
    Mogensen, Carl Erik
    Schernthaner, Gerit-Holger
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (05): : 306 - 323
  • [22] DPP-4 inhibitors associated with acute kidney injury
    Reactions Weekly, 2016, 1605 (1) : 8 - 8
  • [23] The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
    Secrest, Matthew H.
    Udell, Jacob A.
    Filion, Kristian B.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (03) : 194 - 202
  • [24] Newer classes of antidiabetes drugs: ophthalmological considerations for GLP-1R agonists, DPP-4 inhibitors, and SGLT-2 inhibitors
    McReelis, Kylen D.
    Lovshin, Julie A.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2017, 52 : S4 - S7
  • [25] DPP-4 inhibitors in the treatment of type 2 diabetes
    Duez, Helene
    Cariou, Bertrand
    Staels, Bart
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (07) : 823 - 832
  • [26] DPP-4 Inhibitors and GLP-1 Receptor Agonists for Prevention or Delay of Type 2 Diabetes Mellitus and Associated Complications
    Smith, Dustin K.
    Wessner, Matthew J.
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (07) : 437 - 438
  • [27] GLP1R Gene Expression and Kidney Disease Progression
    Triozzi, Jefferson L.
    Yu, Zhihong
    Giri, Ayush
    Chen, Hua-Chang
    Wilson, Otis D.
    Ferolito, Brian
    Ikizler, T. Alp
    Akwo, Elvis A.
    Robinson-Cohen, Cassianne
    Gaziano, John Michael
    Cho, Kelly
    Phillips, Lawrence S.
    Tao, Ran
    Pereira, Alexandre C.
    Hung, Adriana M.
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [28] The Pharmacologic Basis for Clinical Differences Among GLP-1 Receptor Agonists and DPP-4 Inhibitors
    Morales, Javier
    POSTGRADUATE MEDICINE, 2011, 123 (06) : 189 - 201
  • [29] Mortality Differences SGLT-2, DPP-4 Inhibitors and GLP-1 Receptor Agonists
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (03): : 173 - 173
  • [30] Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists
    Payk, Stephanie L.
    Drew, Richard H.
    Smith, Jennifer D.
    Jiroutek, Michael R.
    Holland, Melissa A.
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1477 - 1482
12345